ACR 3.57% 5.4¢ acrux limited

Efinaconazole Topical Solution, page-3

  1. 6,069 Posts.
    lightbulb Created with Sketch. 50
    correct. the whole reason that ACR went the Generics route was initially based on Jublia. Jublia a US$200m plus a year seller. But ACR's win was not a knockout blow in the US Courts. Had ACR ( and some 9-12 other drug coys) been allowed to launch back in 2017 the last 6 years may have been totally different. Jet
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.